Anzeige
Meldung des Tages: Freitagabend nachbörslich veröffentlicht – was der Markt erst am Montag sieht

Mallinckrodt Pharmaceuticals News

Aktie
WKN:  A1W0TN ISIN:  IE00BBGT3753 US-Symbol:  MNKKQ
Keine aktuellen Kursdaten verfügbar
Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Marktkapitalisierung *
-
Streubesitz
94,42%
KGV
-
Index-Zuordnung
-

Mallinckrodt Pharmaceuticals News

22.07.25 - PR Newswire
Mallinckrodt plc to Report Earnings Results for Second Quarter 2025
Mallinckrodt plc to Report Earnings Results for Second Quarter 2025 PR Newswire
16.11.22 - PR Newswire
Mallinckrodt Announces 2022 Advancing Extracorporeal Photopheresis Immunomodulation Investigator Award
Mallinckrodt Announces 2022 Advancing Extracorporeal Photopheresis Immunomodulation Investigator Award PR Newswire
08.11.22 - PR Newswire
Mallinckrodt plc Reports Third Quarter 2022 Financial Results and Reaffirms Guidance
Mallinckrodt plc Reports Third Quarter 2022 Financial Results and Reaffirms Guidance PR Newswire
03.11.22 - PR Newswire
Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Association for the Study of Liver Diseases (AASLD) 2022 Liver Meeting
Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Association for the Study of Liver Diseases ...
01.11.22 - PR Newswire
Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Society of Nephrology (ASN) Kidney Week 2022 Scientific Meeting
Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Society of Nephrology (ASN) Kidney Week ...
03.08.22 - PR Newswire
MALLINCKRODT TO REPORT EARNINGS RESULTS FOR SECOND QUARTER 2022 AND PROVIDE BUSINESS UPDATE
MALLINCKRODT TO REPORT EARNINGS RESULTS FOR SECOND QUARTER 2022 AND PROVIDE BUSINESS UPDATE PR Newswire
16.06.22 - PR Newswire
Mallinckrodt Emerges from Chapter 11 with Strengthened Balance Sheet and Enhanced Financial Flexibility
Mallinckrodt Emerges from Chapter 11 with Strengthened Balance Sheet and Enhanced Financial Flexibility PR Newswire
13.06.22 - PR Newswire
Mallinckrodt Announces Resubmission of Terlipressin to the FDA for the Treatment of Hepatorenal Syndrome
Mallinckrodt Announces Resubmission of Terlipressin to the FDA for the Treatment of Hepatorenal Syndrome PR Newswire
13.06.22 - PR Newswire
Mallinckrodt Announces Anticipated Chapter 11 Emergence and Provides Update on Trading of New Ordinary Shares
Mallinckrodt Announces Anticipated Chapter 11 Emergence and Provides Update on Trading of New Ordinary Shares PR Newswire
28.03.22 - PR Newswire
Retrospective Study on Real-World Treatment Patterns and Outcomes of Acthar® Gel (Repository Corticotropin Injection) in Patients with Refractory Rheumatoid Arthritis Published in Drugs in Context
Retrospective Study on Real-​World Treatment Patterns and Outcomes of Acthar® Gel (Repository Corticotropin Injection) in Patients with Refractory Rheumatoid Arthritis Published ...
22.02.22 - PR Newswire
Mallinckrodt Provides a Regulatory Update on Terlipressin
Mallinckrodt Provides a Regulatory Update on Terlipressin PR Newswire
03.02.22 - PR Newswire
Mallinckrodt Plan of Reorganization Confirmed by U.S. Court
Mallinckrodt Plan of Reorganization Confirmed by U.S. Court PR Newswire
31.01.22 - PR Newswire
Mallinckrodt Earns Top Marks Again in Human Rights Campaign Foundation's 2022 Corporate Equality Index
Mallinckrodt Earns Top Marks Again in Human Rights Campaign Foundation's 2022 Corporate Equality Index For the sixth straight year, Mallinckrodt earns a perfect 100 on the ...
16.12.21 - PR Newswire
Mallinckrodt Announces Enrollment of First Patient in Phase 1/2a StrataSOMA Clinical Trial of StrataGraft® (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen - dsat) for Investigating the Treatment of Full-Thickness Burns
Mallinckrodt Announces Enrollment of First Patient in Phase 1/2a StrataSOMA Clinical Trial of StrataGraft® (allogeneic cultured keratinocytes and dermal fibroblasts in murine ...
13.12.21 - PR Newswire
New Data on Patients with Cutaneous T-cell Lymphoma Treated with Extracorporeal Photopheresis from a Retrospective Study Presented at the American Society of Hematology Annual Meeting
New Data on Patients with Cutaneous T-cell Lymphoma Treated with Extracorporeal Photopheresis from a Retrospective Study Presented at the American Society of Hematology ...
12.11.21 - PR Newswire
Mallinckrodt Presents Results from Two Retrospective Studies on Real World Characteristics and Outcomes of Patients with Hepatorenal Syndrome Type-1 (HRS-1) at The Liver Meeting Digital Experience
Mallinckrodt Presents Results from Two Retrospective Studies on Real World Characteristics and Outcomes of Patients with Hepatorenal Syndrome Type-1 (HRS-1) at The Liver ...
25.10.21 - PR Newswire
Mallinckrodt Presents Results on Real World Treatment Patterns and Outcomes in Hospitalized Patients with Esophageal Variceal Hemorrhage and Liver Cirrhosis Treated with Terlipressin at the American College of Gastroenterology Annual Scientific Meeting
Mallinckrodt Presents Results on Real World Treatment Patterns and Outcomes in Hospitalized Patients with Esophageal Variceal Hemorrhage and Liver Cirrhosis Treated with ...
03.09.21 - PR Newswire
Mallinckrodt Reaches Settlements with the Official Committee of Opioid Related Creditors, the Official Committee of Unsecured Creditors and Second Lien Noteholders
Mallinckrodt Reaches Settlements with the Official Committee of Opioid Related Creditors, the Official Committee of Unsecured Creditors and Second Lien Noteholders Company to ...
02.09.21 - PR Newswire
Mallinckrodt Presents Interim Results on Real World Use of Extracorporeal Photopheresis (ECP) in Heart Transplant Patients in a Late-Breaking Presentation at the 20th Congress of the European Society for Organ Transplantation (ESOT)
Mallinckrodt Presents Interim Results on Real World Use of Extracorporeal Photopheresis (ECP) in Heart Transplant Patients in a Late-​Breaking Presentation at the 20th Congress ...
07.07.21 - PR Newswire
Mallinckrodt Announces Publication of Phase 3 STRATA2016 Study in Burns
Mallinckrodt Announces Publication of Phase 3 STRATA2016 Study in Burns - First publication of full data set shows use of StrataGraft® (allogeneic cultured keratinocytes and ...

Newssuche

Videos

newspaper
29.01.26 -10,12%
Rekordjagd bei Gold! Februar Ausblick & Forecast
Ab 2.2. (Montag) börsentäglich um 18 Uhr FEIERABEND-​TRADING. Echte Trades, strategiebasiert, ... Mehr »